IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Logos Global Management LP

Q2 2022 Holdings

Filed 2022-08-15 | 32 holdings | $157.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics Inc(CYTK)COM NEW23282W605$68.8M1,750,00043.7%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$28.5M1,700,00018.1%
ALX Oncology Hldgs Inc(ALXO)COM00166B105$25.4M3,136,35216.1%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$21.3M1,000,00013.5%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$9.2M650,0005.8%
Century Therapeutics Inc(IPSC)COM15673T100$4.0M476,5592.5%
Apellis Pharmaceuticals Inc(APLS)COM03753U106$67.8K1,500,0000.0%
Ideaya Biosciences Inc(IDYA)COM45166A102$51.8K3,750,0000.0%
Design Therapeutics Inc(DSGN)COM25056L103$39.2K2,797,5010.0%
Sarepta Therapeutics Inc(SRPT)COM803607100$30.0K400,0000.0%
Neurocrine Biosciences Inc(NBIX)COM64125C109$29.2K300,0000.0%
Ventyx Biosciences Inc(VTYX)COM92332V107$28.3K2,312,6800.0%
Horizon Therapeutics PUB LSHSG46188101$27.9K350,0000.0%
Dyne Therapeutics Inc(DYN)COM26818M108$19.9K2,900,0000.0%
Karuna Therapeutics IncCOM48576A100$19.0K150,0000.0%
Dice Therapeutics IncCOM23345J104$15.3K985,2510.0%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$15.2K3,743,8750.0%
Chemocentryx Inc(CCXIEUR)COM16383L106$14.9K600,0000.0%
Fulcrum Therapeutics Inc(FULC)COM359616109$9.6K1,950,0000.0%
Kezar Life Sciences IncCOM49372L100$7.9K950,0000.0%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$1.9K399,8010.0%
Spruce Biosciences IncCOM85209E109$1.7K1,000,0000.0%
Instil BIO IncCOM45783C101$1.7K369,8000.0%
Talaris Therapeutics IncCOM87410C104$1.2K270,9870.0%
Edgewise Therapeutics Inc(EWTX)COM28036F105$1.2K150,0000.0%
Tyra Biosciences Inc(TYRA)COM90240B106$1.2K166,5260.0%
LianbioSPONSORED ADS53000N108$852394,4860.0%
Athira Pharma IncCOM04746L104$671220,0000.0%
Vigil Neuroscience Inc(VIGL)COM92673K108$530205,5950.0%
Pyxis Oncology Inc(PYXS)COMMON STOCK747324101$525220,4340.0%
Nuvalent Inc(NUVL)COM670703107$46033,8870.0%
Nuvation BIO Inc(NUVB/WS)*W EXP 07/07/20267080N119$1966,6660.0%